Logo image of EVEX

EVE HOLDING INC (EVEX) Stock Fundamental Analysis

NYSE:EVEX - New York Stock Exchange, Inc. - US29970N1046 - Common Stock - Currency: USD

6.46  -0.5 (-7.18%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EVEX. EVEX was compared to 67 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of EVEX have multiple concerns. EVEX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EVEX has reported negative net income.
EVEX had a negative operating cash flow in the past year.
In the past 5 years EVEX always reported negative net income.
In the past 5 years EVEX always reported negative operating cash flow.
EVEX Yearly Net Income VS EBIT VS OCF VS FCFEVEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

The Return On Assets of EVEX (-53.14%) is worse than 83.58% of its industry peers.
EVEX has a worse Return On Equity (-212.31%) than 80.60% of its industry peers.
Industry RankSector Rank
ROA -53.14%
ROE -212.31%
ROIC N/A
ROA(3y)-50.36%
ROA(5y)-1976.96%
ROE(3y)-83.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EVEX Yearly ROA, ROE, ROICEVEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

EVEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVEX Yearly Profit, Operating, Gross MarginsEVEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, EVEX has more shares outstanding
EVEX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EVEX has a worse debt to assets ratio.
EVEX Yearly Shares OutstandingEVEX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EVEX Yearly Total Debt VS Total AssetsEVEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

EVEX has an Altman-Z score of 1.96. This is not the best score and indicates that EVEX is in the grey zone with still only limited risk for bankruptcy at the moment.
EVEX has a Altman-Z score of 1.96. This is in the lower half of the industry: EVEX underperforms 71.64% of its industry peers.
EVEX has a Debt/Equity ratio of 1.87. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.87, EVEX is not doing good in the industry: 83.58% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.87
Debt/FCF N/A
Altman-Z 1.96
ROIC/WACCN/A
WACCN/A
EVEX Yearly LT Debt VS Equity VS FCFEVEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 3.60 indicates that EVEX has no problem at all paying its short term obligations.
EVEX has a Current ratio of 3.60. This is in the better half of the industry: EVEX outperforms 79.10% of its industry peers.
EVEX has a Quick Ratio of 3.60. This indicates that EVEX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.60, EVEX belongs to the best of the industry, outperforming 91.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
EVEX Yearly Current Assets VS Current LiabilitesEVEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

EVEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.22%.
EPS 1Y (TTM)-22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, EVEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.44% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-39.34%
EPS Next 2Y-13.18%
EPS Next 3Y-6.91%
EPS Next 5Y17.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVEX Yearly Revenue VS EstimatesEVEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
EVEX Yearly EPS VS EstimatesEVEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVEX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVEX Price Earnings VS Forward Price EarningsEVEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVEX Per share dataEVEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A cheap valuation may be justified as EVEX's earnings are expected to decrease with -6.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.18%
EPS Next 3Y-6.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVE HOLDING INC

NYSE:EVEX (7/28/2025, 2:53:08 PM)

6.46

-0.5 (-7.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)08-12 2025-08-12/bmo
Inst Owners4.84%
Inst Owner Change0.48%
Ins Owners0.41%
Ins Owner Change0.16%
Market Cap1.92B
Analysts80
Price Target6.8 (5.26%)
Short Float %9.9%
Short Ratio13.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.87%
Min EPS beat(2)-10.47%
Max EPS beat(2)14.22%
EPS beat(4)3
Avg EPS beat(4)6.03%
Min EPS beat(4)-10.47%
Max EPS beat(4)15.97%
EPS beat(8)7
Avg EPS beat(8)14.99%
EPS beat(12)10
Avg EPS beat(12)14.97%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 25.27
P/tB 25.27
EV/EBITDA N/A
EPS(TTM)-0.55
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.14%
ROE -212.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.36%
ROA(5y)-1976.96%
ROE(3y)-83.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1969.61%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z 1.96
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1505.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.78%
EPS Next Y-39.34%
EPS Next 2Y-13.18%
EPS Next 3Y-6.91%
EPS Next 5Y17.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-25.03%
EBIT Next 3Y4.59%
EBIT Next 5Y23.33%
FCF growth 1Y-67.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.37%
OCF growth 3YN/A
OCF growth 5YN/A